医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Saguaro and Funakoshi Enter Distribution Agreement to make New Non-Toxic Dye Technology Available to Japan

2022年11月18日 AM01:00
このエントリーをはてなブックマークに追加


 

QUEBEC CITY & TOKYO

Saguaro Technologies inc., a cell culture product company that offers a first-of-a-kind dye technology, and Funakoshi Co., Ltd., a top Japanese distributor of life science reagents and products, announces the establishment of a new distribution agreement where Funakoshi will help Saguaro accelerate sales of its products to the Japanese market.

“We are extremely pleased to enter this strategic partnership with a renown and reputable organization like Funakoshi. Funakoshi has expert knowledge of Japanese life science research, and with their 100 years of existence, they will be of tremendous help in establishing Saguaro’s presence in Japan,” said Felix Lavoie-Perusse, Co-Founder & Chief Commercial Officer. “Funakoshi shares our vision that researchers should have access to the best cell culture technologies to improve drug discovery success.”

“Japanese life science research is well-known for the quality of their research and institutions. Our company is excited for the opportunity to help with breakthrough discoveries in Japan, and we are looking forward to working with a leading distributor like Funakoshi,” continued Louis Turcotte, Co-Founder & Chief Executive Officer.

“We are excited to join force with Saguaro, and to be the distributor of choice for a company that brings innovative cell culture products to the market”, added Tetsuya Ikeda, President and Chief Executive Officer at Funakoshi. “Our catalog of products will be enhanced with products like the ChromaLive non-toxic dye technology. We fondly anticipate to collaborate with Saguaro in making high-value life science research products part of everyday research in Japan.”

About Saguaro
Saguaro offers next-generation cell culture products to help make drug discovery more successful.

Visit Saguaro’s website to learn more:
https://www.saguarobio.com/

About Funakoshi
Funakoshi Co., Ltd. has contributed as a leader to distribute research reagents and instruments for researchers in the life science fields since its foundation. Its corporate mission is to provide high quality products to broad range of customers throughout a domestic and international network. To learn more and to view the product brochure, visit www.funakoshi.co.jp. For more information on Funakoshi, please contact info@funakoshi.co.jp.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221117005005/en/

CONTACT

Félix Lavoie-Pérusse

info@saguarobio.com

同じカテゴリーの記事 

  • Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia
  • エスリのテクノロジーをALS治療開発研究所が治験場所検索に採用
  • ALS Therapy Development Institute利用Esri技术绘制临床试验地图
  • Takeda Receives Approval from European Commission for FRUZAQLA in Previously Treated Metastatic Colorectal Cancer
  • コルマーBNH、ヘモヒムの二重機能で国際競争力を強化